UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Thrombosis and myeloma: it is time to get the elephant out of the room

British journal of haematology, 2021-06, Vol.193 (6), p.1027-1029

Louzada, Martha L.

2021

Volltextzugriff (PDF)

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial

Nature medicine, 2024-02, Vol.30 (2), p.543-551

2024

Volltextzugriff (PDF)

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Circulation (New York, N.Y.), 2012-07, Vol.126 (4), p.448-454

2012

Volltextzugriff (PDF)

Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium

Clinical lymphoma, myeloma and leukemia, 2022-01, Vol.22 (1), p.e41-e56

2022

Volltextzugriff (PDF)

First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium

Clinical lymphoma, myeloma and leukemia, 2023-05, Vol.23 (5), p.340-354

2023

Volltextzugriff (PDF)

Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism

Thrombosis research, 2020-11, Vol.195, p.231-232

2020

Volltextzugriff (PDF)

Efficacy of Low- molecular- weight- heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: A systematic review of randomized controlled trials

Thrombosis research, 2009-04, Vol.123 (6), p.837-844

2009

Volltextzugriff (PDF)

Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies

Blood coagulation & fibrinolysis, 2011-03, Vol.22 (2), p.86-91

2011

Volltextzugriff (PDF)

Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium

Clinical lymphoma, myeloma and leukemia, 2020-07, Vol.20 (7), p.e352-e367

2020

Volltextzugriff (PDF)

Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada

European journal of haematology, 2021-10, Vol.107 (4), p.416-427

2021

Volltextzugriff (PDF)

Screening of Patients with Idiopathic Venous Thromboembolism for Paroxysmal Nocturnal Hemoglobinuria Clones

Thrombosis research, 2015-06, Vol.135 (6), p.1107-1109

2015

Volltextzugriff (PDF)

Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy

Current oncology (Toronto), 2011-04, Vol.18 (2), p.e97-100

2011

Volltextzugriff (PDF)

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study

BMC blood disorders, 2016-03, Vol.16 (7), p.7-7, Article 7

2016

Volltextzugriff (PDF)

Psychological impact of thrombophilia testing in asymptomatic family members

Thrombosis research, 2011-12, Vol.128 (6), p.530-535

2011

Volltextzugriff (PDF)

Outcomes of Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.4901-4901

2021

Volltextzugriff (PDF)

Variable Frailty Categorization Among Real-World Patient with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Blood, 2022-11, Vol.140 (Supplement 1), p.2395-2396

2022

Volltextzugriff (PDF)

Outcomes of Maintenance Treatment Post Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients: A Canadian Single Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.2710-2710

2021

Volltextzugriff (PDF)

Outcomes of Single Versus Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.4893-4893

2021

Volltextzugriff (PDF)

Efficacy and Safety of Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism

Blood, 2019-11, Vol.134 (Supplement_1), p.3675-3675

2019

Volltextzugriff (PDF)

Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.3232-3232

2021

Volltextzugriff (PDF)

Part 1 Results of a Dose-Finding Study of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)

Blood, 2021-11, Vol.138 (Supplement 1), p.1653-1653

2021

Volltextzugriff (PDF)

Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.10002-10004

2022

Volltextzugriff (PDF)

Impact of Daratumumab-Containing Regimens in Outcomes of Subsequent Treatments of Relapsed Multiple Myeloma in Real-World Practice from the Canadian Myeloma Research Group Database

Blood, 2022-11, Vol.140 (Supplement 1), p.7192-7194

2022

Volltextzugriff (PDF)

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

Blood, 2016-12, Vol.128 (22), p.5017-5017

2016

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thrombosis and myeloma: it is time to get the elephant out of the room

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium

First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium

Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism

Efficacy of Low- molecular- weight- heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: A systematic review of randomized controlled trials

Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies

Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium

Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada

Screening of Patients with Idiopathic Venous Thromboembolism for Paroxysmal Nocturnal Hemoglobinuria Clones

Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study

Psychological impact of thrombophilia testing in asymptomatic family members

Outcomes of Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience

Variable Frailty Categorization Among Real-World Patient with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Outcomes of Maintenance Treatment Post Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients: A Canadian Single Center Experience

Outcomes of Single Versus Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience

Efficacy and Safety of Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism

Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial

Part 1 Results of a Dose-Finding Study of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)

Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma

Real-World Results of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Impact of Daratumumab-Containing Regimens in Outcomes of Subsequent Treatments of Relapsed Multiple Myeloma in Real-World Practice from the Canadian Myeloma Research Group Database

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

Suchergebnisse filtern